Fluctuations in macular thickness in patients with diabetic macular oedema treated with anti-vascular endothelial growth factor agents.

Victoria Y WangBlanche L KuoAndrew X ChenKevin WangTyler E Greenlee Thais F ContiRishi P Singh

Published in: Eye (London, England) (2021)

Larger retinal thickness fluctuations are associated with poorer visual outcomes in eyes with DMO treated with anti-VEGF injections. Retinal thickness variability may be an important prognostic biomarker for DMO patients.

Keyphrases

optical coherence tomography
vascular endothelial growth factor
diabetic retinopathy
newly diagnosed
optic nerve
end stage renal disease
endothelial cells
type diabetes
ejection fraction
prognostic factors
ultrasound guided
skeletal muscle
platelet rich plasma
cataract surgery
glycemic control